• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过分层虚拟筛选发现并研究噻唑烷-2,4-二酮类似物作为胰岛素样生长因子-1 受体(IGF-1R)抑制剂的构效关系。

Discovery and SAR of thiazolidine-2,4-dione analogues as insulin-like growth factor-1 receptor (IGF-1R) inhibitors via hierarchical virtual screening.

机构信息

Drug Discovery and Design Center, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China.

出版信息

J Med Chem. 2010 Mar 25;53(6):2661-5. doi: 10.1021/jm901798e.

DOI:10.1021/jm901798e
PMID:20178321
Abstract

Insulin-like growth factor-1 receptor (IGF-1R) is a growth factor receptor tyrosine kinase acting as a critical mediator of cell proliferation and survival. Novel 5-benzylidenethiazolidine-2,4-dione (5) and 5-(furan-2-ylmethylene)thiazolidine-2,4-dione (6) compounds were identified as potent and selective IGF-1R inhibitors via hierarchical virtual screening. Initial SAR and biological activity of the analogues of 5 and 6 with thiazolidine-2,4-dione template are presented, and several inhibitors with low nanomolar potency are reported.

摘要

胰岛素样生长因子-1 受体 (IGF-1R) 是一种生长因子受体酪氨酸激酶,作为细胞增殖和存活的关键介质发挥作用。通过层次虚拟筛选,鉴定出新型 5-亚苄基噻唑烷-2,4-二酮 (5) 和 5-(呋喃-2-基亚甲基)噻唑烷-2,4-二酮 (6) 化合物,它们是有效的、选择性的 IGF-1R 抑制剂。本文介绍了噻唑烷-2,4-二酮模板类似物 5 和 6 的初始 SAR 和生物学活性,并报道了几种具有低纳摩尔效力的抑制剂。

相似文献

1
Discovery and SAR of thiazolidine-2,4-dione analogues as insulin-like growth factor-1 receptor (IGF-1R) inhibitors via hierarchical virtual screening.通过分层虚拟筛选发现并研究噻唑烷-2,4-二酮类似物作为胰岛素样生长因子-1 受体(IGF-1R)抑制剂的构效关系。
J Med Chem. 2010 Mar 25;53(6):2661-5. doi: 10.1021/jm901798e.
2
Discovery of 3,5-disubstituted-1H-pyrrolo[2,3-b]pyridines as potent inhibitors of the insulin-like growth factor-1 receptor (IGF-1R) tyrosine kinase.发现3,5-二取代-1H-吡咯并[2,3-b]吡啶作为胰岛素样生长因子-1受体(IGF-1R)酪氨酸激酶的强效抑制剂。
Bioorg Med Chem Lett. 2009 Jun 1;19(11):3136-40. doi: 10.1016/j.bmcl.2008.12.110. Epub 2009 Jan 6.
3
Discovery of a 2,4-disubstituted pyrrolo[1,2-f][1,2,4]triazine inhibitor (BMS-754807) of insulin-like growth factor receptor (IGF-1R) kinase in clinical development.正在进行临床开发的胰岛素样生长因子受体(IGF-1R)激酶的2,4-二取代吡咯并[1,2-f][1,2,4]三嗪抑制剂(BMS-754807)的发现。
J Med Chem. 2009 Dec 10;52(23):7360-3. doi: 10.1021/jm900786r.
4
ATP non-competitive IGF-1 receptor kinase inhibitors as lead anti-neoplastic and anti-papilloma agents.ATP非竞争性IGF-1受体激酶抑制剂作为主要的抗肿瘤和抗乳头瘤药物。
Eur J Pharmacol. 2007 May 7;562(1-2):1-11. doi: 10.1016/j.ejphar.2007.01.052. Epub 2007 Feb 3.
5
Lead identification to generate 3-cyanoquinoline inhibitors of insulin-like growth factor receptor (IGF-1R) for potential use in cancer treatment.进行先导化合物鉴定,以生成胰岛素样生长因子受体(IGF-1R)的3-氰基喹啉抑制剂,用于癌症治疗的潜在应用。
Bioorg Med Chem Lett. 2009 Jan 1;19(1):62-6. doi: 10.1016/j.bmcl.2008.11.037. Epub 2008 Nov 17.
6
Lead identification to generate isoquinolinedione inhibitors of insulin-like growth factor receptor (IGF-1R) for potential use in cancer treatment.寻找可生成异喹啉二酮类胰岛素样生长因子受体(IGF-1R)抑制剂的先导化合物,用于癌症治疗的潜在用途。
Bioorg Med Chem Lett. 2008 Jun 15;18(12):3641-5. doi: 10.1016/j.bmcl.2008.04.044. Epub 2008 Apr 25.
7
Biochemical and structural characterization of a novel class of inhibitors of the type 1 insulin-like growth factor and insulin receptor kinases.一类新型1型胰岛素样生长因子和胰岛素受体激酶抑制剂的生化及结构特征
Biochemistry. 2005 Jul 12;44(27):9430-40. doi: 10.1021/bi0500628.
8
Discovery and initial SAR of 3-(1H-benzo[d]imidazol-2-yl)pyridin-2(1H)-ones as inhibitors of insulin-like growth factor 1-receptor (IGF-1R).3-(1H-苯并[d]咪唑-2-基)吡啶-2(1H)-酮作为胰岛素样生长因子1受体(IGF-1R)抑制剂的发现及初步构效关系研究
Bioorg Med Chem Lett. 2007 Apr 15;17(8):2317-21. doi: 10.1016/j.bmcl.2007.01.102. Epub 2007 Feb 4.
9
SAR of PXR transactivation in benzimidazole-based IGF-1R kinase inhibitors.苯并咪唑类 IGF-1R 激酶抑制剂中 PXR 反式激活的 SAR 研究。
Bioorg Med Chem Lett. 2010 Mar 1;20(5):1744-8. doi: 10.1016/j.bmcl.2010.01.087. Epub 2010 Jan 21.
10
Screening for small molecule inhibitors of insulin-like growth factor receptor (IGF-1R) kinase: comparison of homogeneous time-resolved fluorescence and 33P-ATP plate assay formats.胰岛素样生长因子受体(IGF-1R)激酶小分子抑制剂的筛选:均相时间分辨荧光法与33P-ATP平板分析法的比较
J Exp Ther Oncol. 2004 Jul;4(2):111-9.

引用本文的文献

1
Molecular Hybrids of Thiazolidinone: Bridging Redox Modulation and Cancer Therapy.噻唑烷二酮的分子杂化物:连接氧化还原调节与癌症治疗
Int J Mol Sci. 2025 Jul 7;26(13):6529. doi: 10.3390/ijms26136529.
2
Structure-Activity Relationship Study and Design Strategies of Hydantoin, Thiazolidinedione, and Rhodanine-Based Kinase Inhibitors: A Two-Decade Review.基于乙内酰脲、噻唑烷二酮和若丹宁的激酶抑制剂的构效关系研究与设计策略:二十年综述
ACS Omega. 2024 Jan 19;9(4):4186-4209. doi: 10.1021/acsomega.3c04749. eCollection 2024 Jan 30.
3
The Insulin Receptor: An Important Target for the Development of Novel Medicines and Pesticides.
胰岛素受体:新型药物和农药开发的重要靶标。
Int J Mol Sci. 2022 Jul 14;23(14):7793. doi: 10.3390/ijms23147793.
4
Synthesis and antibacterial activity of new (2,4-dioxothiazolidin-5-yl/ylidene)acetic acid derivatives with thiazolidine-2,4-dione, rhodanine and 2-thiohydantoin moieties.含噻唑烷-2,4-二酮、若丹宁和2-硫代乙内酰脲部分的新型(2,4-二氧代噻唑烷-5-基/亚基)乙酸衍生物的合成及其抗菌活性
Saudi Pharm J. 2018 May;26(4):568-577. doi: 10.1016/j.jsps.2018.01.016. Epub 2018 Feb 2.
5
Application of computational methods for anticancer drug discovery, design, and optimization.计算方法在抗癌药物发现、设计和优化中的应用。
Bol Med Hosp Infant Mex. 2016 Nov-Dec;73(6):411-423. doi: 10.1016/j.bmhimx.2016.10.006. Epub 2016 Nov 30.
6
5-Ene-4-thiazolidinones - An efficient tool in medicinal chemistry.5-烯-4-噻唑烷酮——药物化学中的一种有效工具。
Eur J Med Chem. 2017 Nov 10;140:542-594. doi: 10.1016/j.ejmech.2017.09.031. Epub 2017 Sep 20.
7
Discriminating agonist and antagonist ligands of the nuclear receptors using 3D-pharmacophores.利用三维药效团区分核受体的激动剂和拮抗剂配体。
J Cheminform. 2016 Sep 6;8(1):43. doi: 10.1186/s13321-016-0154-2. eCollection 2016.
8
Hierarchical virtual screening approaches in small molecule drug discovery.小分子药物发现中的分层虚拟筛选方法。
Methods. 2015 Jan;71:26-37. doi: 10.1016/j.ymeth.2014.07.007. Epub 2014 Jul 27.
9
iDrug: a web-accessible and interactive drug discovery and design platform.iDrug:一个可通过网络访问的交互式药物发现与设计平台。
J Cheminform. 2014 May 23;6:28. doi: 10.1186/1758-2946-6-28. eCollection 2014.
10
Computational methods for drug design and discovery: focus on China.计算方法在药物设计与发现中的应用:聚焦中国。
Trends Pharmacol Sci. 2013 Oct;34(10):549-59. doi: 10.1016/j.tips.2013.08.004. Epub 2013 Sep 11.